Blogs about ANPI - Stockpickr! Your Source for Stock Ideas

Blogs about ANPI

Blogs	Description	Date Updated
Canadian Life Sciences Stocks	Last week, I wrote an article about Canadian Technology Companies. But beyond technology, mining, and oil, Canada is home to over 135 publicly traded life sciences related companies. The following Canadian stocks have market caps above $250 million, and trade either on the New York Stock Exchange or NASDAQ. MDS Inc. (MDZ) is an Ontario based developer of products and services for the development of drugs, and the treatment of diseases, including pharmaceutical contract research services and cont...	May 20, 2008
Thursday's Upgrades and Downgrades	UpgradesBerkshire Hills Bancorp (BHLB)- Sterne Agee Hold » Buy Northwest Banc (NWSB)- Janney Mntgmy Scott Sell » Neutral Beckman Coulter (BEC)- Leerink Swann Mkt Perform » Outperform Rogers Comms (RCI)- BMO Capital Markets Market Perform » Outperform Align Tech (ALGN)- Barrington Research Underperform » Mkt Perform Arris (ARRS)- CL King Accumulate » Strong Buy G&K Svcs (GKSR)- Needham Hold » Buy Dreamworks Animation (DWA)- Wedbush Morgan Hold » Buy SI Inte...	May 01, 2008
Angiotech Pharmaceuticals: Coat your portfolio	Filed under: Hilary On Stocks If you've ever needed a drug-coated stent, there's a good chance it was a Taxus stent, which is made by an alliance of Boston Scientific and Angiotech Pharmaceuticals Inc. (USA) (NASDAQ: ANPI). Angiotech produces drugs that prevent inflammation and infection, and it makes its money by combining these drugs with more traditional medical products. It has recently introduced a new wound closer, as well as a less invasive facelift technology, and it has a number of othe...	May 16, 2007
The 52-Week Low Club	Beazer Homes (BZH) Rival Lennar posts horrible results. Sub-prime and real estate problems keeping taking home builders down. Drops to $30.85 against 52-week high of $69.61. Technical Olympic (TOA) Another home builder. Down to $3.72 from $23. McClatchy Newspapers (MNI) Back on the list again as life gets worse for newspaper stocks. Drops to $31.52 from $50.64. CarMax (KMX) Used car company. Split stock 2.1 ratio. Down to $26.80 from $58.89. Tecumseh Products (TECUA) Delays ann...	March 27, 2007
52-Week Low Club (MAR 26, 2007)	Amgen (AMGN) $57.14 (-1.5%)As the FDA keeps talking up generic biotech drugs, Amgen is the first at risk. It actually closed up 3% from the $57.11 low so it avoided the lows intraday but put in a 52-week low close. Angiotech (ANPI) $5.62 (7.2%)Here's what happens when your partner is in drug eluting stents and a competitor shows better results in a study. Boston Scientific (BSX) $14.22 (-6.5%)Angiotech's dominant partner, when does this one stop? Celebrate Express (BDAY) $8.17 (-3...	March 26, 2007
Two Less Followed Stent-Related Companies At Risk	There are two companies that are not as frequently referred to in stent-land, and depending on how you interpret today's news that stents don't improve lives any better than dugs alone could really bite into these company prospects. The two companies are makers of the molecules that are used in drug-coated stents. SurModics (SRDX) is the molecule maker for J&J (JNJ) Cypher stent; Angiotech (ANPI) is the molecule maker for Boston Scientific's (BSX) Taxus stent. Both of these...	March 26, 2007
Pre-Market Stock News (MAR 19, 2007)	(ABN) ABN AMRO is in an informal acquisition round of talks where Barclays would acquire the company.(ALXN) Alexion Pharma gets FDA marketing approval for Soliris.(ANPI) Angiotech Pharma announces the initiation of its United States study examining the Vascular Wrap Paclitaxel-Eluting Mesh.(ANLT) Analytical Surveys to merge with Ecowood.(AVZA) Aviza Tech received an order for its Sigma fxP physical vapor deposition system from Cension Semiconductor Manufacturing.(CAT) Caterpillar indicated up on...	March 19, 2007

Enter search text here: